
Natus Medical
Leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical.
- Healthcare
- medical devices
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
investor | €0.0 | round | |
* | $1.2b Valuation: $1.2b 2.7x EV/Revenue | Acquisition | |
Total Funding | 000k |

EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | - | - | (7 %) | (16 %) | 13 % | 2 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | - | - | (4 %) | (3 %) | (4 %) | 5 % | 7 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | - | - | 11 % | 12 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Natus Medical was founded in 1989 by two visionary entrepreneurs, Dr. David Burton and Dr. William E. Brown. The company set out with a mission to improve the standard of care in newborn health. Over the years, Natus expanded its focus to include a wide range of healthcare solutions, including neurology, sleep, hearing, and balance disorders.
In its early years, Natus Medical made significant strides in developing innovative medical devices and software that addressed critical needs in the healthcare industry. The company's commitment to quality and innovation quickly established it as a leader in the medical device sector.
A pivotal moment in Natus Medical's journey came in 2022 when the company agreed to be acquired by ArchiMed, a healthcare-focused private equity firm. The acquisition deal, valued at approximately $1.2 billion, marked a significant milestone in Natus's history. This move was aimed at leveraging ArchiMed's strategic and financial resources to further expand Natus's product lines and global reach.
Throughout its journey, Natus Medical has remained dedicated to its core mission of advancing patient care through innovative solutions. The company's story is a testament to the impact of strategic growth and the importance of staying true to one's founding principles while adapting to the evolving healthcare landscape.
Tech stack
Investments by Natus Medical
Edit



